ATE408843T1 - Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin - Google Patents
Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetaminInfo
- Publication number
- ATE408843T1 ATE408843T1 AT02080462T AT02080462T ATE408843T1 AT E408843 T1 ATE408843 T1 AT E408843T1 AT 02080462 T AT02080462 T AT 02080462T AT 02080462 T AT02080462 T AT 02080462T AT E408843 T1 ATE408843 T1 AT E408843T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- hapten
- aforementioned
- mdma
- methylenedioxymethamphetamin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/807—Hapten conjugated with peptide or protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/13—Tracers or tags
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01205058 | 2001-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE408843T1 true ATE408843T1 (de) | 2008-10-15 |
Family
ID=39777868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02080462T ATE408843T1 (de) | 2001-12-20 | 2002-12-17 | Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin |
Country Status (7)
Country | Link |
---|---|
US (2) | US7217802B2 (de) |
EP (1) | EP1321772B1 (de) |
CN (1) | CN1281626C (de) |
AT (1) | ATE408843T1 (de) |
DE (1) | DE60228927D1 (de) |
ES (1) | ES2316520T3 (de) |
HK (1) | HK1053700A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2316520T3 (es) * | 2001-12-20 | 2009-04-16 | Randox Laboratories Ltd. | Metodo y conjunto para detectar, o determinar, la 3,4-metilenodioximetanfetamina. |
US7169907B2 (en) * | 2002-03-01 | 2007-01-30 | Roche Diagnostics Operations, Inc. | Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
US7060847B2 (en) * | 2003-07-18 | 2006-06-13 | Roche Diagnostics Operations, Inc. | Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs |
US20050130243A1 (en) * | 2003-12-15 | 2005-06-16 | Zheng Yi F. | Assay for entactogens |
US6991911B2 (en) | 2003-12-15 | 2006-01-31 | Dade Behring Inc. | Assay for entactogens |
US7022492B2 (en) | 2003-12-15 | 2006-04-04 | Dade Behring Inc. | Ecstasy haptens and immunogens |
US7115383B2 (en) | 2004-03-22 | 2006-10-03 | Dade Behring Inc. | Assays for amphetamine and methamphetamine |
US7037669B2 (en) | 2004-03-22 | 2006-05-02 | Dade Behring Inc. | Assays for amphetamine and methamphetamine using stereospecific reagents |
GB201313938D0 (en) | 2013-08-05 | 2013-09-18 | Randox Lab Ltd | Immunoassay for phenethylamines of the 2C and DO sub-families |
GB201409516D0 (en) | 2014-05-29 | 2014-07-16 | Randox Lab Ltd | Immunoassay for compounds of the NBOMe family |
CN114890958B (zh) * | 2022-02-23 | 2023-10-20 | 四川警察学院 | 双光子染料化合物、其制备方法及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5101015A (en) * | 1989-04-10 | 1992-03-31 | Abbott Laboratories | Reagents for an amphetamine-class fluorescence polarization immunoassay |
US6207396B1 (en) * | 1995-11-20 | 2001-03-27 | Microgenics Corporation | Immunoassay reagents and methods for determination of LSD and LSD metabolites |
DE19630102A1 (de) * | 1996-07-25 | 1998-01-29 | Boehringer Mannheim Gmbh | Neue aktivierte Amphetamine |
GB2361473C (en) * | 2000-03-08 | 2005-06-28 | Microgenics Corp | Ecstasy-class analogs and use of same in detection of ecstasy-class compounds |
ES2316520T3 (es) * | 2001-12-20 | 2009-04-16 | Randox Laboratories Ltd. | Metodo y conjunto para detectar, o determinar, la 3,4-metilenodioximetanfetamina. |
US7169907B2 (en) * | 2002-03-01 | 2007-01-30 | Roche Diagnostics Operations, Inc. | Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs |
US6991911B2 (en) * | 2003-12-15 | 2006-01-31 | Dade Behring Inc. | Assay for entactogens |
US7022492B2 (en) * | 2003-12-15 | 2006-04-04 | Dade Behring Inc. | Ecstasy haptens and immunogens |
-
2002
- 2002-12-17 ES ES02080462T patent/ES2316520T3/es not_active Expired - Lifetime
- 2002-12-17 DE DE60228927T patent/DE60228927D1/de not_active Expired - Lifetime
- 2002-12-17 AT AT02080462T patent/ATE408843T1/de not_active IP Right Cessation
- 2002-12-17 EP EP02080462A patent/EP1321772B1/de not_active Expired - Lifetime
- 2002-12-20 CN CN02139960.3A patent/CN1281626C/zh not_active Expired - Fee Related
- 2002-12-20 US US10/326,742 patent/US7217802B2/en not_active Expired - Lifetime
-
2003
- 2003-08-20 HK HK03105961A patent/HK1053700A1/xx not_active IP Right Cessation
-
2007
- 2007-04-03 US US11/695,815 patent/US20090280499A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090280499A1 (en) | 2009-11-12 |
ES2316520T3 (es) | 2009-04-16 |
CN1429844A (zh) | 2003-07-16 |
US20040121400A1 (en) | 2004-06-24 |
HK1053700A1 (en) | 2003-10-31 |
DE60228927D1 (de) | 2008-10-30 |
US7217802B2 (en) | 2007-05-15 |
EP1321772A1 (de) | 2003-06-25 |
CN1281626C (zh) | 2006-10-25 |
EP1321772B1 (de) | 2008-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE408843T1 (de) | Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin | |
EE05465B1 (et) | Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt | |
DE69836888D1 (de) | Verfahren für Fluoreszenzerkennungstest | |
DE69831601D1 (de) | Testkit und verfahren zum nachweis eines analyten | |
DE59708311D1 (de) | Volumenunabhängiger diagnostischer Testträger und Verfahren zur Bestimmung von Analyten mit dessen Hilfe | |
ATE490978T1 (de) | Verfahren mit beziehung zu linearen baken | |
ATE112059T1 (de) | Verfahren zur bestimmung eines analyten. | |
ATE496917T1 (de) | Haptene, immunogene, antikörper und konjugate für 2-oxo-3-hydroxy lsd | |
DE68925058T2 (de) | Verfahren zum frühzeitigen Nachweis von Lungenkrebs | |
DE60207016D1 (de) | Verfahren und Kit zur Quantifizierung von Beta-Laktam Penizillinen | |
ATE456799T1 (de) | Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern | |
ATE347105T1 (de) | Verfahren, assay und kit zur quantifizierung von hiv-proteasehemmer | |
DE602005023784D1 (de) | Blockierter enzymsondenkomplex | |
DE69942215D1 (de) | Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers | |
ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
ATE284034T1 (de) | Verfahren zum nachweis von protein s | |
ATE277352T1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
ATE336724T1 (de) | Verfahren zum testen auf morbus crohn und testkit dafür | |
ATA8822001A (de) | Verfahren und messeinrichtung zur bestimmung zumindest eines lumineszenz-, floureszenz- oder absorptionsparameters einer probe | |
DE59409491D1 (de) | Verfahren zum Nachweis metabolisch markierter DNA | |
DE69922680D1 (de) | Detektion und quantifikation von vancomycin in den biologischen flüssigkeiten | |
ATE414904T1 (de) | Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo | |
ATE437368T1 (de) | Verfahren zum prüfen von mit wt1-verbundenen krankheiten | |
DE69920981D1 (de) | Knorpelresorptionsassays | |
DE10158713A8 (de) | Träger mit immobilisierten Antigenen oder Antikörpern und Verfahren zu dessen Herstellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
REN | Ceased due to non-payment of the annual fee |